Found: 14
Select item for more details and to access through your institution.
Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 411, doi. 10.1002/pds.5412
- By:
- Publication type:
- Article
Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 2019.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 481, doi. 10.1002/pds.5411
- By:
- Publication type:
- Article
Sampling in the case‐time‐control design among drug users when outcome prevents further treatment.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 404, doi. 10.1002/pds.5410
- By:
- Publication type:
- Article
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 424, doi. 10.1002/pds.5403
- By:
- Publication type:
- Article
Assessing adverse event reports of hysteroscopic sterilization device removal using natural language processing.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 442, doi. 10.1002/pds.5402
- By:
- Publication type:
- Article
Validation of diagnosis codes to identify hospitalized COVID‐19 patients in health care claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 476, doi. 10.1002/pds.5401
- By:
- Publication type:
- Article
Validity of self‐reports of medication treatment of depression in general population surveys.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 461, doi. 10.1002/pds.5400
- By:
- Publication type:
- Article
Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 434, doi. 10.1002/pds.5399
- By:
- Publication type:
- Article
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 467, doi. 10.1002/pds.5398
- By:
- Publication type:
- Article
Use of negative control outcomes to assess the comparability of patients initiating lipid‐lowering therapies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 383, doi. 10.1002/pds.5396
- By:
- Publication type:
- Article
Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 393, doi. 10.1002/pds.5391
- By:
- Publication type:
- Article
Validity of a model using routinely collected data for identifying infections following gastric, colon, and liver cancer surgeries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 452, doi. 10.1002/pds.5386
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 488, doi. 10.1002/pds.5274
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article